Interestingly, in the group of patients with combined strong GRP78 and GRP94 protein expression levels, an association with either early (pT1) or advanced (pT3) tumor stages, while patients with pT2 tumors showed moderate GRP78 and GRP94 protein expression levels. This evidence concerns the gene HSPA5 and neoplasm.